CellChorus
South San Francisco
About CellChorus
CellChorus provides a comprehensive, dynamic analysis of single cells for biopharmaceutical companies. The company’s TIMING™ platform applies visual AI to evaluate cell activation, killing and movement as a function of time in order to maximize our understanding of the cellular function, state, and phenotype of immuno-oncology and other therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.1M
- Funding stage: Seed
- Last round: Grant (Aug 2025)
- Website: cellchorus.com
- Phone: [email protected]
Industries & Categories
Analytics, Artificial Intelligence (AI), Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/cellchorus-27420 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.